Heterocyclic Compounds as Dipeptidyl Peptidase-IV Inhibitors with Special Emphasis on Oxadiazoles as Potent Anti-Diabetic Agents

Dipeptidyl peptidase-IV (DPP-IV) inhibitors, often known as gliptins, have been used to treat type 2 diabetes mellitus (T2DM). They may be combined with other medications as an additional treatment or used alone as a monotherapy. In addition to insulin, sulfonylureas, thiazolidinediones, and metform...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohammad, Badrud Duza, Baig, Mirza Shahed, Bhandari, Neeraj, Siddiqui, Falak A., Khan, Sharuk L., Ahmad, Zubair, Khan, Farhat S., Tagde, Priti, Jeandet, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502781/
https://www.ncbi.nlm.nih.gov/pubmed/36144735
http://dx.doi.org/10.3390/molecules27186001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502781/
https://www.ncbi.nlm.nih.gov/pubmed/36144735
http://dx.doi.org/10.3390/molecules27186001

Ejemplares similares